Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetes

(Before It's News)

Where size matters

Diabetic cases have increased rapidly in recent years throughout the world. Currently, for type-1 diabetes mellitus (T1DM), multiple daily insulin (MDI) injections is the most popular treatment throughout the world. At this juncture, researchers are trying to develop different insulin delivery systems, especially through oral and pulmonary route using nanocarrier based delivery system. This next generation efficient therapy for T1DM may help to improve the quality of life of diabetic patients who routinely employ insulin by the subcutaneous route. In this paper, we have depicted various next generation nanocarrier based insulin delivery systems such as chitosan-insulin nanoparticles, PLGA-insulin nanoparticles, dextran-insulin nanoparticles, polyalkylcyanoacrylated-insulin nanoparticles and solid lipid-insulin nanoparticles. Modulation of these insulin nanocarriers may lead to successful oral or pulmonary insulin nanoformulations in future clinical settings. Therefore, applications and limitations of these nanoparticles in delivering insulin to the targeted site have been thoroughly discussed.
Garima Sharma
Click for full article

• Design and optimization of peptide nanoparticles
• Cerium oxide nanoparticles attenuate acute kidney injury induced by intra-abdominal infection in Sprague–Dawley rats
• Version 4.0 of the Montage Image Mosaic Engine Released: Data Cubes and more.
• Comics of the week #310
• Is Eric Dollard Tesla 2.0?
• Next Future modular transportation swarms the commuting hordes
• Aston Martin previews possible all-electric Rapide sedan
• Green Car Congress: GM and LG expand their relationship on Bolt EV; 12 components, including PEEM
• Volvo Unveils Global Electrification Strategy – CarNewsCafe.com
• OnePlus now gives you 3 days to use your OnePlus 2 invite instead of just 24 hours